Konrad Paszkiewicz

Konrad Paszkiewicz has served as the Chief Technology Officer of Hummingbird Bioscience since October 2017. Dr. Paszkiewicz leads Hummingbird’s internal platform technologies, including mAbPredict, biomarker discovery and omics-technologies such as single-cell analysis and spatial transcriptomics, machine learning and high performance computing and IT infrastructure. Between 2016 and 2017 Dr. Paszkiewicz was Director of the Wellcome Trust Biomedical Informatics Hub and the Head of the Genomics Sequencing Facility at the University of Exeter, UK. Dr. Paszkiewicz holds an MSci in Physics and a PhD in Bioinformatics from Imperial College, London.

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Hummingbird Bioscience

1 followers

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.


Employees

51-200

Links